Beer molecule discovery bolsters Seattle biotech upstart
on 27/01/13 at 11:16 amBooze News
Scientists have delved deeply into the molecular structure of a compound found in bitter beer, notching a discovery that could aid the Seattle startup KinDex Pharmaceuticals’ advance of new drugs for diabetes and other diseases.
Using good old X-ray crystallography, University of Washington chemistry professor Werner Kaminsky found previously unknown variation in the structure of humulones, a bitter acid from hops found in beer, that could have a significant impact on the use of the compound in medicines, UW’s The Daily reported. The discovery centers on the two different atomic arrangements for the molecule–what chemists call handedness.